Evidence map›Paper›PMID 40105820›Full record

ArticleInvestigative ophthalmology & visual science2025

An Approach to Predict Intraocular Diseases by Machine Learning Based on Vitreous Humor Immune Mediator Profile.

Risa Sugawara, Yoshihiko Usui, Akira Saito, Naoya Nezu, Hiroyuki Komatsu, Kinya Tsubota, Masaki Asakage, Naoyuki Yamakawa, Yoshihiro Wakabayashi, Masahiro Sugimoto and 2 more

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Risa SugawaraDepartment of Ophthalmology, Tokyo Medical University Hospital, Tokyo, Japan.
Yoshihiko UsuiDepartment of Ophthalmology, Tokyo Medical University Hospital, Tokyo, Japan.
Akira SaitoDepartment of AI Applied Quantitative Clinical Science, Tokyo Medical University, Tokyo, Japan.
Naoya NezuDepartment of Ophthalmology, Tokyo Medical University Hospital, Tokyo, Japan.
Hiroyuki KomatsuDepartment of Ophthalmology, Tokyo Medical University Hospital, Tokyo, Japan.
Kinya TsubotaDepartment of Ophthalmology, Tokyo Medical University Hospital, Tokyo, Japan.
Masaki AsakageDepartment of Ophthalmology, Tokyo Medical University Hospital, Tokyo, Japan.
Naoyuki YamakawaDepartment of Ophthalmology, Tokyo Medical University Hospital, Tokyo, Japan.
Yoshihiro WakabayashiDepartment of Ophthalmology, Tokyo Medical University Hospital, Tokyo, Japan.
Masahiro SugimotoResearch and Development Center for Minimally Invasive Therapies, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
Masahiko KurodaDepartment of Molecular Pathology, Tokyo Medical University, Tokyo, Japan.
Hiroshi GotoDepartment of Ophthalmology, Tokyo Medical University Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to elucidate whether machine learning algorithms applied to vitreous levels of immune mediators predict the diagnosis of 12 representative intraocular diseases, and identify immune mediators driving the predictive power of machine learning model. Methods: Vitreous samples in 522 eyes diagnosed with 12 intraocular diseases were collected, and 28 immune mediators were measured using a cytometric bead array. The significance of each immune mediator was determined by employing five machine learning algorithms. Stratified k-fold cross-validation was performed to divide the dataset into training and test sets. The algorithms were assessed by analyzing precision, recall, accuracy, F-score, area under the receiver operating characteristics curve, area under the precision-recall curve, and feature importance. Results: Of the five machine learning models, random forest attained the maximum accuracy in the classification of 12 intraocular diseases in a multi-class setting. The random forest prediction models for vitreoretinal lymphoma, endophthalmitis, uveal melanoma, rhegmatogenous retinal detachment, and acute retinal necrosis demonstrated superior classification accuracy, precision, and recall. The top three important immune mediators for predicting vitreoretinal lymphoma were IL-10, granzyme A, and IL-6; those for endophthalmitis were IL-6, G-CSF, and IL-8; and those for uveal melanoma were RANTES, IL-8 and bFGF. Conclusions: The random forest algorithm effectively classified 28 immune mediators in the vitreous to accurately predict the diagnosis of vitreoretinal lymphoma, endophthalmitis, and uveal melanoma among 12 representative intraocular diseases. In summary, the results of this study enhance our understanding of potential new biomarkers that may contribute to elucidating the pathophysiology of intraocular diseases in the future.

Indexed as

CytokinesEye DiseasesMachine LearningVitreous BodyAdultAgedAlgorithmsBiomarkersFemaleHumansMaleMiddle AgedROC CurveBiomarkersCytokines

Identifiers

PMID40105820
PMCPMC11932427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.